Katuschia Germé, Dhillon Persad, Justine Petit-Robinson, Shimon Amir, James G Pfaus
{"title":"d-安非他明对雄性大鼠条件性抑制的破坏作用。","authors":"Katuschia Germé, Dhillon Persad, Justine Petit-Robinson, Shimon Amir, James G Pfaus","doi":"10.1007/s00213-025-06786-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Male rats trained to associate a neutral odor (almond) with nonreceptive females during their initial sexual experiences develop a conditioned sexual inhibition (CSI) toward the female bearing the olfactory cue when given a choice in a final copulatory preference test between two receptive females (one unscented and one scented) in an open field. We have previously shown that this CSI can be abolished by acute alcohol before the final copulatory preference test.</p><p><strong>Objective: </strong>To examine whether acute treatment with d-amphetamine could also disrupt CSI.</p><p><strong>Methods: </strong>Male rats received 20 alternating conditioning sessions with an unscented receptive female or an almond-scented non-receptive female. Forty minutes prior to the copulatory preference test with two receptive females, one unscented and the other scented (almond extract), males were injected with saline or one of three doses of d-amphetamine (d- 0.5, 1.0, or 2.0 mg/kg). After two reconditioning trials, males were injected with d-amp or saline and exposed to the olfactory cue alone for 1 h. Brains were fixed and processed for immunohistochemical analysis of Fos protein as a marker of neuronal activation. Fos expression was assessed in several brain regions involved in male sexual behavior.</p><p><strong>Results: </strong>Saline-treated males displayed inhibition of copulatory behavior directed toward the scented female. In contrast, and regardless of the dose, males treated with d-amp prior to the final test copulated with both scented and unscented females, indicating that d-amp disrupted the CSI. Exposure to d-amphetamine and the odor alone induced a differential pattern of Fos expression in several brain areas involved in the expression and/or the regulation of male sexual behavior.</p><p><strong>Conclusions: </strong>As observed previously with alcohol, a low dose of d-amphetamine disrupted the display of a CSI by acting on brain regions mediating sexual behavior.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Disruptive effects of d-amphetamine on conditioned sexual inhibition in the male rat.\",\"authors\":\"Katuschia Germé, Dhillon Persad, Justine Petit-Robinson, Shimon Amir, James G Pfaus\",\"doi\":\"10.1007/s00213-025-06786-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale: </strong>Male rats trained to associate a neutral odor (almond) with nonreceptive females during their initial sexual experiences develop a conditioned sexual inhibition (CSI) toward the female bearing the olfactory cue when given a choice in a final copulatory preference test between two receptive females (one unscented and one scented) in an open field. We have previously shown that this CSI can be abolished by acute alcohol before the final copulatory preference test.</p><p><strong>Objective: </strong>To examine whether acute treatment with d-amphetamine could also disrupt CSI.</p><p><strong>Methods: </strong>Male rats received 20 alternating conditioning sessions with an unscented receptive female or an almond-scented non-receptive female. Forty minutes prior to the copulatory preference test with two receptive females, one unscented and the other scented (almond extract), males were injected with saline or one of three doses of d-amphetamine (d- 0.5, 1.0, or 2.0 mg/kg). After two reconditioning trials, males were injected with d-amp or saline and exposed to the olfactory cue alone for 1 h. Brains were fixed and processed for immunohistochemical analysis of Fos protein as a marker of neuronal activation. Fos expression was assessed in several brain regions involved in male sexual behavior.</p><p><strong>Results: </strong>Saline-treated males displayed inhibition of copulatory behavior directed toward the scented female. In contrast, and regardless of the dose, males treated with d-amp prior to the final test copulated with both scented and unscented females, indicating that d-amp disrupted the CSI. Exposure to d-amphetamine and the odor alone induced a differential pattern of Fos expression in several brain areas involved in the expression and/or the regulation of male sexual behavior.</p><p><strong>Conclusions: </strong>As observed previously with alcohol, a low dose of d-amphetamine disrupted the display of a CSI by acting on brain regions mediating sexual behavior.</p>\",\"PeriodicalId\":20783,\"journal\":{\"name\":\"Psychopharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00213-025-06786-y\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-025-06786-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Disruptive effects of d-amphetamine on conditioned sexual inhibition in the male rat.
Rationale: Male rats trained to associate a neutral odor (almond) with nonreceptive females during their initial sexual experiences develop a conditioned sexual inhibition (CSI) toward the female bearing the olfactory cue when given a choice in a final copulatory preference test between two receptive females (one unscented and one scented) in an open field. We have previously shown that this CSI can be abolished by acute alcohol before the final copulatory preference test.
Objective: To examine whether acute treatment with d-amphetamine could also disrupt CSI.
Methods: Male rats received 20 alternating conditioning sessions with an unscented receptive female or an almond-scented non-receptive female. Forty minutes prior to the copulatory preference test with two receptive females, one unscented and the other scented (almond extract), males were injected with saline or one of three doses of d-amphetamine (d- 0.5, 1.0, or 2.0 mg/kg). After two reconditioning trials, males were injected with d-amp or saline and exposed to the olfactory cue alone for 1 h. Brains were fixed and processed for immunohistochemical analysis of Fos protein as a marker of neuronal activation. Fos expression was assessed in several brain regions involved in male sexual behavior.
Results: Saline-treated males displayed inhibition of copulatory behavior directed toward the scented female. In contrast, and regardless of the dose, males treated with d-amp prior to the final test copulated with both scented and unscented females, indicating that d-amp disrupted the CSI. Exposure to d-amphetamine and the odor alone induced a differential pattern of Fos expression in several brain areas involved in the expression and/or the regulation of male sexual behavior.
Conclusions: As observed previously with alcohol, a low dose of d-amphetamine disrupted the display of a CSI by acting on brain regions mediating sexual behavior.
期刊介绍:
Official Journal of the European Behavioural Pharmacology Society (EBPS)
Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:
Human Psychopharmacology: Experimental
This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.
Human Psychopharmacology: Clinical and Translational
This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.
Preclinical psychopharmacology: Behavioral and Neural
This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.
Preclinical Psychopharmacology: Translational
This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.
Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic
This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.